Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders' Equity

v3.4.0.3
Consolidated Statements of Shareholders' Equity - 3 months ended Mar. 31, 2016 - USD ($)
$ in Thousands
Capital Stock
Warrants
Contributed Surplus
Accumulated Other Comprehensive Income
Deficit
Total
Beginning Balance at Dec. 31, 2015 $ 168,911 $ 4,175 $ 14,632 $ 3,357 $ (158,574) $ 32,501
Beginning Balance (in shares) at Dec. 31, 2015 130,188,775          
Exercise of stock options $ 13   (4)     $ 9
Exercise of stock options (in shares) 16,620         16,620
Common shares issued for cash, net $766 of issue costs $ 5,694         $ 5,694
Common shares issued for cash, net of issue costs (in shares) 12,921,000          
Redemption of vested RSUs $ 256   (267)     (11)
Redemption of vested RSUs (in shares) 314,178          
Expiry of warrants   (66) 66      
Non-cash stock compensation     209     209
Net loss and comprehensive (loss) income       252 (2,989) (2,737)
Ending Balance at Mar. 31, 2016 $ 174,874 $ 4,109 $ 14,636 $ 3,609 $ (161,563) $ 35,665
Ending Balance (in shares) at Mar. 31, 2016 143,440,573